首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3146893篇
  免费   278568篇
  国内免费   15009篇
耳鼻咽喉   43690篇
儿科学   96768篇
妇产科学   81223篇
基础医学   506806篇
口腔科学   86510篇
临床医学   281902篇
内科学   546439篇
皮肤病学   85192篇
神经病学   272769篇
特种医学   125913篇
外国民族医学   201篇
外科学   494786篇
综合类   104499篇
现状与发展   29篇
一般理论   2181篇
预防医学   266832篇
眼科学   71582篇
药学   218097篇
  32篇
中国医学   10163篇
肿瘤学   144856篇
  2021年   55082篇
  2020年   35298篇
  2019年   58206篇
  2018年   70524篇
  2017年   53810篇
  2016年   59454篇
  2015年   74037篇
  2014年   108324篇
  2013年   173402篇
  2012年   84566篇
  2011年   82559篇
  2010年   114424篇
  2009年   119941篇
  2008年   69430篇
  2007年   71598篇
  2006年   82748篇
  2005年   78259篇
  2004年   80803篇
  2003年   72067篇
  2002年   61608篇
  2001年   84592篇
  2000年   76523篇
  1999年   80252篇
  1998年   63177篇
  1997年   61643篇
  1996年   59341篇
  1995年   54861篇
  1994年   49202篇
  1993年   46003篇
  1992年   57394篇
  1991年   54653篇
  1990年   51858篇
  1989年   51439篇
  1988年   48195篇
  1987年   47121篇
  1986年   44918篇
  1985年   45493篇
  1984年   43551篇
  1983年   40219篇
  1982年   40260篇
  1981年   38104篇
  1980年   36020篇
  1979年   36889篇
  1978年   33522篇
  1977年   30831篇
  1976年   28046篇
  1975年   26569篇
  1974年   27687篇
  1973年   26601篇
  1972年   25038篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
53.
54.
55.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment.  相似文献   
56.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
57.
58.
59.
60.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号